- United Therapeutics (NASDAQ:UTHR) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open.
- The consensus EPS Estimate is $4.05 (+22.4% Y/Y) and the consensus Revenue Estimate is $427.59M (+11.1% Y/Y).
- Over the last 2 years, UTHR has beaten EPS estimates 75% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 2 downward.
United Therapeutics Q4 2021 Earnings Preview
Recommended For You
More Trending News
About UTHR Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
UTHR | - | - |
United Therapeutics Corporation |